アドバイザリーボード

Joseph B. Bolen, Ph.D., Chief Scientific Officer, Millennium Pharmaceuticals

Illana Gozes, Ph.D., Chief Scientific Officer, Allon Therapeutics

Brian Hubbard, Ph.D., Diabetes and Metabolism, Novartis Institutes for BioMedical Research

Jason Kim, Ph.D., Associate Professor, Cellular & Molecular Physiology, Pennsylvania State University College of Medicine

Alan Louie, Ph.D., Research Director, Health Industry Insights, IDC

Rose A. Maciewicz, Ph.D., Chief Scientist, Respiratory and Inflammation Research Area, AstraZeneca, United Kingdom

Michael McCully, Director & Senior Analyst, Recombinant Capital, Inc.

Matthew Pando, Ph.D., Vice President, R&D, ExonHit Therapeutics

David J. Payne, Director and Head of Microbiology, Infectious Diseases Center of Excellence for Drug Discovery (CEDD), GlaxoSmithKline

Norton P. Peet, Ph.D., Pharmaceutical Industry Consultant

Georg C. Terstappen, Ph.D., Vice President, Discovery Research, Siena Biotech, Italy

Chengbin Wu, Ph.D., Senior Scientist and Project Leader, Abbott Bioresearch